Nearly half a million people are diagnosed and treated for Lyme disease in the U.S. every year, and Pennsylvania is a hot bed ...
Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme ...
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...
When Lyme disease makes the news, it's typically not for positive reasons — but Pfizer is gearing up to seek regulatory ...
Pfizer said its experimental Lyme disease vaccine was more than 70% efficacious in reducing confirmed cases of the tickborne ...
12d
Pfizer to seek FDA approval for Lyme vaccine as CT report shows ticks are more abundant than ever
The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...
ROANOKE, Va. (WDBJ) - Pfizer said it plans to seek regulatory approval of a new vaccine for Lyme disease. Vaccines for Lyme ...
In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...
Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results